And it gets worse!
NOTE 23: SUBSEQUENT EVENTS
Between January 1, 2024 and March 28, 2024, the Company issued 1,698,247,010 shares of common stock as follows: 1,174,627,010 shares in conversion of debt, 50,000,000 shares for services rendered, 393,300,000 shares in exchange of warrants, and 80,320,000 shares of common stock in conversion of 8,032 shares of Series B preferred stock.
On January 4, 2024, the Company entered into a Convertible Promissory Note in the amount of $55,000, due October 30, 2024. The note accrues interest at 9%, and an original issue discount of $5,000 was reflected that provided net proceeds of $50,000 to the Company. The note is convertible at a 35% discount to the lowest trade price of the common stock in the previous 10 trading days.
On February 22, 2024, the Company entered into a Promissory Note in the amount of $220,000, due February 22, 2025. A one-time interest charge of $22,000 was added to the note, and an original issue discount of $20,000 was reflected that provided net proceeds of $200,000 to the Company. In connection with this note, the Company issued a Warrant to Purchase Shares of Common Stock for 100,000,000 shares. The warrant is exercisable for three years and has an exercise price of $0.001.
On February 12, 2024, the Company entered into a Promissory Note in the amount of $55,000, due February 12, 2025. A one-time interest charge of $5,500 was added to the note, and an original issue discount of $5,000 was reflected that provided net proceeds of $50,000 to the Company. In connection with this note, the Company issued a Warrant to Purchase Shares of Common Stock for 25,000,000 shares. The warrant is exercisable for three years and has an exercise price of $0.001.
On February 14, 2024, the Company entered into a Promissory Note in the amount of $66,000, due November 15, 2024. A one-time interest charge of $9,900 was added to the note, and an original issue discount of $11,000 was reflected that provided net proceeds of $50,000 to the Company.
On February 23, 2024, the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Avrio Worldwide, PBC (“Avrio”). Pursuant to the Purchase Agreement, the Company sold the assets associated with its HUMBL Financial product line, including all BLOCK ETXs and BLOCK Indexes (but not including any active trading algorithms or strategies) to Avrio. In exchange for selling such assets, HUMBL received: (1) 1,920,000 shares of Avrio’s Class A Common Stock that has one vote per share (representing a 10% stake in Avrio); and (2) 2.5% of the net revenues generated by Avrio from its sales of the acquired assets. The revenue share terminates upon the earlier of five years from the date of the Purchase Agreement or Avrio completing an initial public offering. The Company will also receive a seat on Avrio’s Board of Directors as part of the transaction, the initial designee being Brian Foote, CEO of the Company. The Company is currently evaluating the consideration received from Avrio in the determination of the value of the investment.
On March 13, 2024, the Company entered into a Promissory Note in the amount of $121,000, due March 13, 2025. A one-time interest charge of $12,100 was added to the note, and an original issue discount of $11,000 was reflected that provided net proceeds of $110,000 to the Company. In connection with this note, the Company issued a Warrant to Purchase Shares of Common Stock for 55,000,000 shares. The warrant is exercisable for three years and has an exercise price of $0.001.
On March 26, 2024, the Company entered into a Promissory Note in the amount of $121,000, due March 26, 2025. A one-time interest charge of $12,100 was added to the note, and an original issue discount of $11,000 was reflected that provided net proceeds of $110,000 to the Company. In connection with this note, the Company issued a Warrant to Purchase Shares of Common Stock for 55,000,000 shares. The warrant is exercisable for three years and has an exercise price of $0.001.
